January 8, 2018
Targovax welcomes new business leader
Targovax ASA, a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announced on Monday that Michael…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Targovax
September 25, 2017
Targovax protects its neoantigen vaccines in USA for RAS-mutated cancers
Targovax has obtained the patent from the US Patent and Trademark Office for it’s mutant-RAS specific neoantigen vaccines, TG01 and…
September 15, 2017
Nordic Star Awards was presented at the NLSDays conference
Herantis Pharma, Targovax, Pelago get the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden. Nordic Stars…
September 11, 2017
Targovax with three oncology posters at ESMO in Spain
Targovax ASA, a clinical stage company focused on immuno-oncology therapies against solid tumors, on Monday revealed that three posters were…